Protagenic Therapeutics Successfully Concludes Third Cohort

Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders

Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

New York , United States , Massachusetts , , Company Contact , Advisory Inc , Nasdaq , Protagenic Therapeutics Inc , Protagenic Therapeutics , Protocol Progress , Treatment Resistant Depression , Generalized Anxiety , Maurizio Fava , Massachusetts General Hospital , Principal Investigator , Axiom Real Time Metrics , Data Analytics , Corticotropin Releasing Factor , Looking Statements , Protagenic Therapeutic , Chief Financial Officer , Relations Contact ,